© 2019 Smart + Strong. All Rights Reserved. Terms of use and Your privacy. Smart + Strong® is a registered trademark of CDM Publishing, LLC.
Short treatment interruptions of antiretroviral regimens are both safe and well-tolerated, which is good news for scientists pursuing cures.
New research shows Stribild, a.k.a. the Quad, is as effective and safe as Atripla in those who don’t adhere perfectly to their regimens.
People with undetectable viral loads experience same rates of virologic control whether they undergo checkups every three or six months.
Hospital admission rates for people coinfected with both HIV and hepatitis C slightly more than doubled.
Only 38 percent of those linked to HIV care while in jail maintain steady checkups after release.
Mistakes are common when it comes to prescribing antiretrovirals to people living with HIV who have been hospitalized.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.
